Technicals for Eris Lifesciences Limited
The PSAR continues its bullish outlook, reinforcing a crucial support level that...
The PSAR continues its bullish outlook, reinforcing a crucial support level that...
With positive gross and operating margins, ERIS demonstrates strong profitability. This reflects...
The list of all important regulatory filings for Eris Lifesciences Limited which...
An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...
An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...
An investor-focused analysis of major shifts in the financial services landscape as...
| Published | Title | Summary |
|---|---|---|
| 2025-02-21 08:28:56 | Agreements | Eris Lifesciences Limited has informed the Exchange about Agreements... |
| 2025-02-04 20:24:44 | Board Meeting Intimation | Eris Lifesciences Limited has informed the Exchange about Board Meeting... |
| 2025-02-04 20:06:00 | Record Date | Eris Lifesciences Limited has informed the Exchange that Record date... |
| 2025-01-29 11:37:30 | Board Meeting Intimation | ERIS LIFESCIENCES LIMITED has informed the Exchange about Board Meeting... |
| 2024-08-03 10:56:42 | Acquisition-XBRL | Eris Lifesciences Limited has informed the Exchange regarding Acquisition... |
| 2024-08-02 14:52:05 | Acquisition | Eris Lifesciences Limited has informed the Exchange about Acquisition... |
| 2024-07-30 18:24:36 | Board Meeting Intimation | ERIS LIFESCIENCES LIMITED has informed the Exchange about Board Meeting... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
An article analysing how new U.S. tariff policies are contributing to economic...
An article exploring Oracle’s latest quarterly results that reveal a significant AI...
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...